Arena Pharma's (ARNA) Licensing Deal Is A Match Made In Heaven - Credit Suisse
Tweet Send to a Friend
Credit Suisse analyst, Martin Auster, reiterated his Outperform rating on shares of Arena Pharma (NASDAQ: ARNA) and raised his price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
